UPDATE: Goldman Sachs Downgrades Express Scripts Holding Company


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


In a note released Thursday morning, Goldman Sachs analyst Robert Jones downgraded shares of Express Scripts Holding Company (NASDAQ: ESRX) from Buy to Neutral and maintained a $75 price target.

Jones' downgrade comes on the sentiment that Express shares have adequately priced in the company's growth prospects. Jones commented, "While ESRX will continue to play a critical role in reducing client drug spend, we do not see generics, mail, and formulary tools driving historic organic growth rates."

Looking to the company's balance sheet, Jones noted Express has plenty of "M&A firepower." However, he said there a few M&A opportunities within Express's core business. This means any M&A activity would likely be outside the company's core and thus pose integration risks.


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Analyst ColorNewsDowngradesPrice TargetAnalyst RatingsGoldman SachsRobert Jones